Vaccination and Public Health Strategy

Dear Colleagues,

Immunization is one of the most cost-effective health interventions. It prevents 3.5–5 million deaths and saves 2–3 million children from vaccine-preventable diseases every year. Ensuring the effective and sustainable implementation of all national immunization programs is crucial in order to achieve the Immunization Agenda 2030 vision of a “world where everyone, everywhere, at all ages fully benefits from vaccines for good health and well-being”.

We welcome original research articles, systematic reviews, and case studies that examine the challenges associated with introducing new vaccines, guided by the recommendations of the World Health Organization (WHO), and welcome innovative approaches to financing and managing national immunization programs, including innovative interventions that facilitate equitable access to vaccines. Manuscripts that discuss national strategies for vaccine procurement, supply chain management, and public–private partnerships that promote the sustainability of immunization are particularly encouraged.

This Special Issue provides an excellent opportunity for researchers and health professionals to share insights regarding the provision of sustainable and equitable immunization programs worldwide. We look forward to receiving contributions that advance knowledge regarding vaccination and the strengthening of the health system in developing countries.

Dr. Shenglan Tang
Dr. Lance E. Rodewald
Dr. Taufique Joarder
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.